US Stock MarketDetailed Quotes

ANEB Anebulo Pharmaceuticals

Watchlist
  • 1.640
  • +0.020+1.24%
Close Jan 7 16:00 ET
67.38MMarket Cap-5.47P/E (TTM)

Anebulo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
38.02%-1.69M
16.44%-8.09M
27.95%-2.05M
31.64%-1.5M
30.49%-1.81M
-34.07%-2.73M
-78.09%-9.68M
-42.52%-2.85M
-49.91%-2.19M
-117.68%-2.61M
Net income from continuing operations
11.29%-2.2M
30.09%-8.2M
45.91%-1.35M
40.90%-1.65M
28.99%-2.72M
5.02%-2.48M
-71.89%-11.73M
-7.44%-2.5M
-49.11%-2.8M
-256.66%-3.83M
Other non cash items
--59.7K
--151.23K
--59.7K
--59.7K
----
----
----
----
----
----
Change In working capital
135.93%164.13K
-168.64%-799.26K
-62.82%-939.85K
-114.38%-55.17K
-34.21%652.56K
-224.80%-456.8K
28.28%1.16M
-697.96%-577.23K
32.35%383.79K
550.78%991.91K
-Change in receivables
---245.36K
----
----
----
----
--0
----
----
----
----
-Change in prepaid assets
196.45%100.85K
-98.53%8.96K
-22.70%-190.11K
-119.59%-51.94K
417.10%355.57K
-124.36%-104.56K
-4.50%608.21K
53.08%-154.95K
4.31%265.11K
-79.64%68.76K
-Change in payables and accrued expense
187.62%308.64K
-245.29%-808.22K
-77.54%-749.74K
-102.73%-3.24K
-67.83%297K
-456.65%-352.24K
105.34%556.27K
-198.95%-422.28K
231.21%118.68K
265.51%923.15K
Cash from discontinued investing activities
Operating cash flow
38.02%-1.69M
16.44%-8.09M
27.95%-2.05M
31.64%-1.5M
30.49%-1.81M
-34.07%-2.73M
-78.09%-9.68M
-42.52%-2.85M
-49.91%-2.19M
-117.68%-2.61M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-100.98%-62.35K
0
0
6.38M
-68.16K
0
-248.93K
Net common stock issuance
----
--0
--0
--0
----
----
--6.65M
--0
--0
--0
Proceeds from stock option exercised by employees
----
--0
--0
--0
----
----
--52.4K
--0
--0
--0
Net other financing activities
----
80.34%-62.35K
--0
--0
----
----
---317.08K
---68.16K
--0
----
Cash from discontinued financing activities
Financing cash flow
----
-100.98%-62.35K
--0
--0
----
----
--6.38M
---68.16K
--0
---248.93K
Net cash flow
Beginning cash position
-72.49%3.09M
-22.69%11.25M
-63.66%5.15M
-59.37%6.64M
-55.65%8.52M
-22.69%11.25M
-27.21%14.55M
-14.40%14.16M
-9.18%16.36M
0.03%19.21M
Current changes in cash
38.02%-1.69M
-146.99%-8.15M
29.63%-2.05M
31.64%-1.5M
34.37%-1.88M
-158.45%-2.73M
39.29%-3.3M
-45.92%-2.92M
-49.91%-2.19M
-138.44%-2.86M
End cash Position
-83.52%1.4M
-72.49%3.09M
-72.49%3.09M
-63.66%5.15M
-59.37%6.64M
-55.65%8.52M
-22.69%11.25M
-22.69%11.25M
-14.40%14.16M
-9.18%16.36M
Free cash flow
38.02%-1.69M
16.44%-8.09M
27.95%-2.05M
31.64%-1.5M
30.49%-1.81M
-34.07%-2.73M
-78.09%-9.68M
-42.52%-2.85M
-49.91%-2.19M
-117.68%-2.61M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Sep 30, 2024 (FY)Jun 30, 2024 (Q4)Jun 30, 2024 (Q3)Mar 31, 2024 (Q2)Dec 31, 2023 (Q1)Sep 30, 2023 (FY)Jun 30, 2023 (Q4)Jun 30, 2023 (Q3)Mar 31, 2023 (Q2)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 38.02%-1.69M 16.44%-8.09M 27.95%-2.05M 31.64%-1.5M 30.49%-1.81M -34.07%-2.73M -78.09%-9.68M -42.52%-2.85M -49.91%-2.19M -117.68%-2.61M
Net income from continuing operations 11.29%-2.2M 30.09%-8.2M 45.91%-1.35M 40.90%-1.65M 28.99%-2.72M 5.02%-2.48M -71.89%-11.73M -7.44%-2.5M -49.11%-2.8M -256.66%-3.83M
Other non cash items --59.7K --151.23K --59.7K --59.7K ---- ---- ---- ---- ---- ----
Change In working capital 135.93%164.13K -168.64%-799.26K -62.82%-939.85K -114.38%-55.17K -34.21%652.56K -224.80%-456.8K 28.28%1.16M -697.96%-577.23K 32.35%383.79K 550.78%991.91K
-Change in receivables ---245.36K ---- ---- ---- ---- --0 ---- ---- ---- ----
-Change in prepaid assets 196.45%100.85K -98.53%8.96K -22.70%-190.11K -119.59%-51.94K 417.10%355.57K -124.36%-104.56K -4.50%608.21K 53.08%-154.95K 4.31%265.11K -79.64%68.76K
-Change in payables and accrued expense 187.62%308.64K -245.29%-808.22K -77.54%-749.74K -102.73%-3.24K -67.83%297K -456.65%-352.24K 105.34%556.27K -198.95%-422.28K 231.21%118.68K 265.51%923.15K
Cash from discontinued investing activities
Operating cash flow 38.02%-1.69M 16.44%-8.09M 27.95%-2.05M 31.64%-1.5M 30.49%-1.81M -34.07%-2.73M -78.09%-9.68M -42.52%-2.85M -49.91%-2.19M -117.68%-2.61M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -100.98%-62.35K 0 0 6.38M -68.16K 0 -248.93K
Net common stock issuance ---- --0 --0 --0 ---- ---- --6.65M --0 --0 --0
Proceeds from stock option exercised by employees ---- --0 --0 --0 ---- ---- --52.4K --0 --0 --0
Net other financing activities ---- 80.34%-62.35K --0 --0 ---- ---- ---317.08K ---68.16K --0 ----
Cash from discontinued financing activities
Financing cash flow ---- -100.98%-62.35K --0 --0 ---- ---- --6.38M ---68.16K --0 ---248.93K
Net cash flow
Beginning cash position -72.49%3.09M -22.69%11.25M -63.66%5.15M -59.37%6.64M -55.65%8.52M -22.69%11.25M -27.21%14.55M -14.40%14.16M -9.18%16.36M 0.03%19.21M
Current changes in cash 38.02%-1.69M -146.99%-8.15M 29.63%-2.05M 31.64%-1.5M 34.37%-1.88M -158.45%-2.73M 39.29%-3.3M -45.92%-2.92M -49.91%-2.19M -138.44%-2.86M
End cash Position -83.52%1.4M -72.49%3.09M -72.49%3.09M -63.66%5.15M -59.37%6.64M -55.65%8.52M -22.69%11.25M -22.69%11.25M -14.40%14.16M -9.18%16.36M
Free cash flow 38.02%-1.69M 16.44%-8.09M 27.95%-2.05M 31.64%-1.5M 30.49%-1.81M -34.07%-2.73M -78.09%-9.68M -42.52%-2.85M -49.91%-2.19M -117.68%-2.61M
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- Unqualified Opinion -- -- -- -- Unqualified Opinion -- -- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Symbol Mini Chart % Chg
Ecopetrol
EC
+3.01%
Petroleo Brasileiro SA Petrobras
PBR
+2.74%
Alphabet-C
GOOG
-0.63%
Vale SA
VALE
-0.70%
Alphabet-A
GOOGL
-0.70%

Unlock the Full List